Global Pharmatech Statistics
Global Pharmatech (GBLP) Stock Statistics & Valuation Metrics
Total Valuation
Global Pharmatech has a market cap or net worth of $33.25M. The enterprise value is $33.24T.
- Market Cap
- $33.25M
- Enterprise Value
- $33.24T
Share Statistics
Global Pharmatech has 415,211,800 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 415,211,800
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
Global Pharmatech’s return on equity (ROE) is 0.56 and return on invested capital (ROIC) is 169.86%.
- Return on Equity (ROE)
- 0.56
- Return on Assets (ROA)
- -0.09
- Return on Invested Capital (ROIC)
- 169.86%
- Return on Capital Employed (ROCE)
- 0.56
- Revenue Per Employee
- 1,432.696
- Profits Per Employee
- -312.111
- Employee Count
- 217
- Asset Turnover
- 0.41
- Inventory Turnover
- 9.90
Valuation Ratios
The current PE Ratio of Global Pharmatech is 800.90. Global Pharmatech’s PEG ratio is 16.02.
- PE Ratio
- 800.90
- PS Ratio
- 67.00
- PB Ratio
- -3671.26
- Price to FCF
- -415.99
- Price to Operating Cash Flow
- -636.30
- PEG Ratio
- 16.02
Income Statement
In the last 12 months, Global Pharmatech had revenue of 310.89K and earned -67.73K in profits. Earnings per share was -0.00.
- Revenue
- 310.89K
- Gross Profit
- 34.66K
- Operating Income
- -67.81K
- Pretax Income
- -67.73K
- Net Income
- -67.73K
- EBITDA
- -59.91K
- Earnings Per Share (EPS)
- -0.00
Cash Flow
In the last 12 months, operating cash flow was -52.26K and capital expenditures -27,676, giving a free cash flow of -79.94K billion.
- Operating Cash Flow
- -52.26K
- Free Cash Flow
- -79.94K
- Free Cash Flow per Share
- -0.00
Dividends & Yields
Global Pharmatech pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -0.24%
- Earnings Yield
- 0.12%
Stock Price Statistics
- Beta
- -0.48
- 52-Week Price Change
- 60.00%
- 50-Day Moving Average
- 0.08
- 200-Day Moving Average
- 0.07
- Relative Strength Index (RSI)
- ―
- Average Volume (3m)
- ―
Financial Position
Global Pharmatech as a current ratio of 0.44, with Debt / Equity ratio of -66.82%
- Current Ratio
- 0.44
- Quick Ratio
- 0.41
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- -0.85
- Interest Coverage Ratio
- -113.24
Taxes
In the past 12 months, Global Pharmatech has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
Global Pharmatech EV to EBITDA ratio is 809.06, with an EV/FCF ratio of -415.80.
- EV to Sales
- 66.96
- EV to EBITDA
- 809.06
- EV to Free Cash Flow
- -415.80
- EV to Operating Cash Flow
- -636.00
Balance Sheet
Global Pharmatech has $106.13K in cash and marketable securities with $90.63K in debt, giving a net cash position of $15.50K billion.
- Cash & Marketable Securities
- $106.13K
- Total Debt
- $90.63K
- Net Cash
- $15.50K
- Net Cash Per Share
- $0.00
- Tangible Book Value Per Share
- $0.00
Margins
Gross margin is 25.63%, with operating margin of 7.83%, and net profit margin of 7.76%.
- Gross Margin
- 25.63%
- Operating Margin
- 7.83%
- Pretax Margin
- 7.76%
- Net Profit Margin
- 7.76%
- EBITDA Margin
- 8.28%
- EBIT Margin
- 7.95%
Analyst Forecast
The average price target for Global Pharmatech is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- 0
- Revenue Growth Forecast
- ―
- EPS Growth Forecast
- ―
